BioCentury
ARTICLE | Company News

Luqa Pharmaceuticals, NewBridge Pharmaceuticals sales and marketing update

April 30, 2012 7:00 AM UTC

Luqa granted NewBridge exclusive rights to develop and commercialize antifungal Ebernet eberconazole 1% cream in undisclosed countries in the Middle and East Africa. NewBridge is responsible for regu...